Identification of Major Subclinical Symptoms of Malaria among Carriers in Owerri, Nigeria


  • (1)  Eteike. O. P.            Federal Medical Center, Owerri, Imo State, Nigeria  
            Uzbekistan

  • (2)  Oparaocha. E. T            Dept of Public Health, Federal University of Technology, Owerri, Imo State, Nigeria  
            Uzbekistan

  • (3)  Onwuka. C. D.            Department of Animal and Environmental Biology, Imo State University Owerri, Nigeria  
            Uzbekistan

    (*) Corresponding Author

DOI:

https://doi.org/10.47494/mesb.v16i.747

Keywords:

Subclinical symptoms, malaria, Southeast Nigeria

Abstract

Malaria remains a life-threatening disease with significant public health implications, especially in Sub-Saharan Africa. Malaria can be detected early, which can lead to earlier care and a reduction in morbidity and disease burden. Researchers in Owerri, Nigeria, decided to learn more about subclinical malaria symptoms. The study took place in two communities: Naze and Ikenegbu, both of which are suburbs of Owerri metropolis, between September and December.ated early.

Downloads

Download data is not yet available.

References

Beare NA, Taylor TE, Harding SP, Lewallen S, & Molyneux ME (2006). Malarial retinopathy: A newly established diagnostic sign in severe malaria. American Journal of Tropical Medicine and Hygiene; 75 (5): 790–7.

Bartoloni A. & Zammarchi L (2012).Clinical aspects of uncomplicated and severe malaria. Mediterranean Journal of Hematology and Infectious Disease; 4(1): 2014-2026.

Chukwuocha UM, Chukwuocha AN, Udujih OG, Amadi CN, Nwoke EA & Ibeh SNO (2016). Malaria among the geriatric population in parts of South-Eastern Nigeria: prevalence, complications, and co-morbidity with non-communicable diseases. Epidemiology (Sunnyvale); 6:237.

Chukwura BM, Fidock DA, Kyle DIE, Kappe SH, Alonso P, et al (2008). Malaria: progress, perils, and prospects for eradication. Journal of Clinical Investigation; 118:1266-1276.

Eteike PO & Oparaocha ET (2017):. Therapeutic Efficacy of Artemether-Lumefantrine in Subclinical Malaria in Southeastern Nigeria. International Journal of Translational Medical Research and Public Health; 1 (2): 22-28

Ferri FF. (2009). Protozoan infections. Ferris’s Color Atlas and Text of Clinical Medicine. Elsevier Health Sciences. p. 1159. ISBN 978-1-4160-4919-7.

Nadjm B, Behrens RH & Malaria (2012). An update for physicians. Infectious Disease Clinics of North America; 26 (2): 243–59.

Joice R1, Nilsson SK1, Montgomery J, Dankwa SL, Egan E1, et al. (2014). Plasmodium falciparum transmission stages accumulate in the human bone marrow. Science Translational Medicine; 9: 6(244):244re5.

Ukpai OM & Ajoku EI (2001). The prevalence of malaria in Okigwe and Owerri areas of Imo state. Nigeria Journal of Parasitology; 22: 43-48.

WHO. World Malaria Report (2015).World Health Organization, Geneva, Switzerland; 2015. http://apps.who.int/iris/bitstream/10665/200018/1/9789241565158_eng.pdf.accessed 20 July 2016.

WHO (2012). World Malaria Report. World Health Organization, Geneva, Switzerland; 2012. Available at http://www.who.int/malaria/publications/world_malaria_ report_2012/en/, accessed 20 July 2016.

WHO (2015). Guidelines for the treatment of malaria.3rd ed. WHO, Geneva, Switzerland; 2015.Available at http://www.who.int/malaria/publications/atoz/ 9789241549127/en/.Retrieved on June 20, 2016.

Wikimedia Foundation. Owerri. Available at https://en.wikipedia.org/wiki/Owerri_North, retrieved 26 July 2016

WHO (2002). Rollback malaria. World Health Organization Fact Sheet No. 2003. WHO, Geneva, Switzerland; Available at https://apps.who.int/inf-fs/en/fact203.html, retrieved on 21, July 2016.

WHO (1991). Basic Malaria Microscopy. WHO, Geneva, Switzerland; 1991.

Published

2021-10-05

How to Cite

P., E. O. ., T, O. E. ., & D., O. C. . (2021). Identification of Major Subclinical Symptoms of Malaria among Carriers in Owerri, Nigeria. Middle European Scientific Bulletin, 16. https://doi.org/10.47494/mesb.v16i.747

Issue

Section

Medicine